Enlivex Therapeutics Ltd. (ENLV)
NASDAQ: ENLV · Real-Time Price · USD
1.130
+0.030 (2.73%)
Feb 5, 2026, 9:54 AM EST - Market open
Enlivex Therapeutics Market Cap
Enlivex Therapeutics has a market cap or net worth of $268.24 million as of February 5, 2026. Its market cap has increased by 925.09% in one year.
Market Cap
268.24M
Enterprise Value
243.62M
1-Year Change
925.09%
Ranking
Category
Stock Price
$1.13
Market Cap Chart
Since March 26, 2019, Enlivex Therapeutics's market cap has increased from $101.63M to $268.24M, an increase of 163.94%. That is a compound annual growth rate of 15.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 4, 2026 | 261.12M | 56.43% |
| Dec 31, 2025 | 166.93M | 548.82% |
| Dec 31, 2024 | 25.73M | -48.77% |
| Dec 29, 2023 | 50.22M | -30.73% |
| Dec 30, 2022 | 72.50M | -36.72% |
| Dec 31, 2021 | 114.57M | -5.58% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 26, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Abeona Therapeutics | 275.29M |
| Aardvark Therapeutics | 273.47M |
| Fennec Pharmaceuticals | 271.18M |
| Rezolute | 269.84M |
| Coherus Oncology | 268.33M |
| Relmada Therapeutics | 267.67M |
| Cellectis | 266.56M |
| Neurogene | 266.11M |